Cipaglucosidase alfa

Pombiliti

105 MG / VIAL Powder For SolutionCanadaMarketedAuthorised 5 Dec 2025

Open in the registerAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Pombiliti 105 MG Polvo Para Concentrado Para Solucion Para PerfusionSpain · 105 mg · polvo para concentrado para solución para perfusión · Amicus Therapeutics Europe LimitedSame brand
PombilitiEuropean Union · Amicus Therapeutics Europe LimitedSame brand
PombilitiCroatiaSame brand
PombilitiItaly · Polvere per concentrato per soluzione per infusione · Amicus Therapeutics Europe LimitedSame brand
Pombiliti 105mg, poeder voor concentraat voor oplossing voor injectie/infusieNetherlands · Poeder voor concentraat voor oplossing voor infusie · Amicus Therapeutics Europe LimitedSame brand

Documents

The official texts, at the regulator.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Cipaglucosidase alfa

Pombiliti

105 MG / VIAL Powder For SolutionCanadaMarketedAuthorised 5 Dec 2025

Open in the registerAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Documents

The official texts, at the regulator.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Register entryHealth Canada

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Health Canada, Canada

Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada · Added 13 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Cipaglucosidase alfa
Strength: 105 MG / VIAL
Dosage form: Powder For Solution
Route: Intravenous
Register: Canada (Health Canada)
Status: Marketed
Authorised: 5 Dec 2025
Registration: DIN 02556898
Marketing authorisation holder: Amicus Therapeutics Canada INC.
ATC code: A16AB23
Group: Alimentary tract and metabolism
Supply: PRESCRIPTION, SCHEDULE D